Western blot

Polypharmacy in Psychiatry: A Review.

Published May 17, 2013

Polypharmacy in psychiatry: a review.

Mens Sana Monogr. 2013 Jan; 11(1): 82-99
Kukreja S, Kalra G, Shah N, Shrivastava A

Psychiatric polypharmacy refers to the prescription of two or more psychiatric medications concurrently to a patient. It can be… Continue reading →

A Review of Potential Harmful Interactions Between Anticoagulant/Antiplatelet Agents and Chinese Herbal Medicines.

Published May 15, 2013

A Review of Potential Harmful Interactions between Anticoagulant/Antiplatelet Agents and Chinese Herbal Medicines.

PLoS One. 2013; 8(5): e64255
Tsai HH, Lin HW, Lu YH, Chen YL, Mahady GB

BACKGROUND: The risks attributed to drug-herb interactions, even when known, are… Continue reading →

Sustained EKR Inhibition by EGFR Targeting Therapies Is a Predictive Factor for Synergistic Cytotoxicity With PDT as Neoadjuvant Therapy.

Published May 15, 2013

Sustained EKR inhibition by EGFR targeting therapies is a predictive factor for synergistic cytotoxicity with PDT as neoadjuvant therapy.

Biochim Biophys Acta. 2013 Mar; 1830(3): 2659-70
Weyergang A, Selbo PK, Berg K

Tyrosin kinase inhibitors (TKIs) and monoclonal antibodies… Continue reading →

Comparison of Responses of Human Melanoma Cell Lines to MEK and BRAF Inhibitors.

Published May 11, 2013

Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors.

Front Genet. 2013; 4: 66
Stones CJ, Kim JE, Joseph WR, Leung E, Marshall ES, Finlay GJ, Shelling AN, Baguley BC

The NRAS and BRAF genes… Continue reading →

Correlation of Angiogenic Biomarker Signatures With Clinical Outcomes in Metastatic Colorectal Cancer Patients Receiving Capecitabine, Oxaliplatin, and Bevacizumab.

Published May 2, 2013

Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab.

Cancer Med. 2013 Apr; 2(2): 234-42
Liu Y, Starr MD, Bulusu A, Pang H, Wong NS, Honeycutt W, Amara A, Hurwitz… Continue reading →

Investigation of Possible Epistatic Interactions Between GRIA2 and GRIA4 Variants on Clinical Outcomes in Patients With Major Depressive Disorder.

Published April 25, 2013

Investigation of possible epistatic interactions between GRIA2 and GRIA4 variants on clinical outcomes in patients with major depressive disorder.

J Int Med Res. 2013 Apr 15;
Chiesa A, Lia L, Lia C, Lee SJ, Han C, Patkar AA, Pae… Continue reading →

Antibiotic Resistance and Carriage Class 1 and 2 Integrons in Clinical Isolates of Acinetobacter Baumannii From Tehran, Iran.

Published April 19, 2013

Antibiotic resistance and carriage class 1 and 2 integrons in clinical isolates of Acinetobacter baumannii from Tehran, Iran.

Asian Pac J Trop Biomed. 2013 Feb; 3(2): 140-145
Mirnejad R, Mostofi S, Masjedian F, Fooladi AA

To investigate antibiotic resistance… Continue reading →

Gestational Nicotine Exposure Modifies Myelin Gene Expression in the Brains of Adolescent Rats With Sex Differences.

Published April 18, 2013

Gestational nicotine exposure modifies myelin gene expression in the brains of adolescent rats with sex differences.

Transl Psychiatry. 2013; 3: e247
Cao J, Wang J, Dwyer JB, Gautier NM, Wang S, Leslie FM, Li MD

Myelination defects in the… Continue reading →

[Pathomechanisms of Autoantibody Production Against the Nervous System].

Published April 10, 2013

[Pathomechanisms of Autoantibody Production against the Nervous System].

Brain Nerve. 2013 Apr; 65(4): 323-32
Arimura K

Abstract In immune-mediated neurological disorders, the production of autoantibodies against the nervous system occurs mainly because of impaired immune tolerance. In myasthenia gravis… Continue reading →

Functional Characteristics of C-Terminal Lysine to Cysteine Mutant Form of CTLA-4Ig.

Published April 7, 2013

Functional Characteristics of C-terminal Lysine to Cysteine Mutant Form of CTLA-4Ig.

Immune Netw. 2013 Feb; 13(1): 16-24
Kim B, Shin JS, Park CG

CTLA-4Ig is regarded as an inhibitory agent of the T cell proliferation via blocking the costimulatory… Continue reading →